Welcome to The Body PRO Newsletter, a bi-weekly review of the latest breaking news and research in HIV medicine, aimed specifically at informing health care professionals.

March 30, 2011

In This Newsletter:


HIV Care Today is a multi-author blog featuring people on the frontlines of HIV treatment, prevention and patient/client care. This blog serves as a platform for health care professionals to discuss the everyday challenges of their jobs, recent developments in their fields and issues relevant to the evolution of HIV/AIDS care.

David FawcettDavid Fawcett: The Healing Power of Being Present
Sometimes, the best thing we can do for our patients or clients is just to listen to them, explains David Fawcett, Ph.D., L.C.S.W.: "Practicing acceptance of, as well as curiosity about, that patient in front of you can keep the experience grounded in a way that not only benefits the health of patient but the satisfaction and resilience of the clinician."

Paul Sax, M.D.Paul E. Sax: Friday Fosfomycins
Paul Sax, M.D., shares quick thoughts on the kidney transplant HIV transmission story, the use of ceftaroline to treat methicillin-resistant Staphylococcus aureus, a discouraging take on "test and treat," and rumors about the date and location of CROI 2012.

Nelson VergelNelson Vergel: An Activist's View of Promising HIV Treatment Research
"As we fear more and more budget cuts; AIDS Drug Assistance Program (ADAP) problems ... and other concerns that keep popping up when attempting to control this epidemic, there are rays of hope that emerge, and motivate many of us working in treatment and research advocacy to keep moving forward," writes Nelson Vergel, B.S.Ch.E., M.B.A.

  Back to Top


Doctors: Is 44% effectiveness for PrEP enough?
Patient safety must come first. Sign on to a letter urging the FDA to wait to approve Truvada for widespread HIV prevention use until further studies are completed.

  Back to Top


CROI 2011 Wrap-Up: Taking Research Into Practice (Video)
Joel Gallant, M.D., takes a step back from the presented research at CROI 2011 to discuss the practical implications of recent developments in the field, including biomedical HIV prevention, the dry drug development pipeline, unanswered questions about inflammation, and the "when to start treatment" question.

Lower Limb Fat, Higher Belly Fat Associated With Mortality in HIV-Infected Patients
Rebecca Scherzer, Ph.D., summarizes the findings of a study she presented at CROI 2011 that appears to call into question the widespread use of body mass index as an effective tool for measuring the muscle mass and body fat changes that may place HIV-infected patients at increased mortality risk.

Much HAART-Related Bone Loss Occurs Early in Therapy, Related to Immune Recovery, Study Finds
Bone resorption in HIV-infected people who initiate antiretroviral therapy occurs primarily during the early phase of treatment, and may be attributable to a patient's level of immune reconstitution, explains researcher Ighovwerha Ofotokun, M.D.

FDA Approves Once-Daily Formulation of Nevirapine
The U.S. Food and Drug Administration (FDA) gave its blessing this week to a 400 mg nevirapine (Viramune) tablet indicated for once-daily dosing. The new dose comes with the same caution against nevirapine administration in adult women with high CD4 counts, as well as a requirement that its use be preceded by a 14-day lead-in period using the 200 mg twice-daily dose.

More Headlines on HIV Treatment & Complications:

  Back to Top


Taxation of Disability Benefits for People With HIV in U.S.
As tax day nears for your HIV-infected clients in the U.S., be sure to remind those receiving disability benefits that they may not be exempt from having to file and pay federal taxes. In this article from Being Alive, Jacques Chambers provides the 411 on what to expect from the IRS.

Indecent Proposals: How Three Medicaid Reforms Could Harm Low-Income New Yorkers With HIV
Recently, the New York State Medicaid Redesign Team submitted 79 proposals to repair and restructure its program. The HIV advocacy organization Housing Works explains its opposition to a few proposals that it says could lead to less access to quality dental care and higher co-pay costs for families.

More News Headlines:

  Back to Top


ScotCharlesScotCharles in Egypt: Taking a Chance, With No Regrets
Long-term HIV survivor ScotCharles returned from his trip to Egypt mere days before the revolution began. Though his health was indeed compromised, as was his safety, "all in all the risk was worth it," he writes. "You should not put off anything that you can do today."

Sarah and Carmen Anthony SaccoSarah and Carmen Anthony Sacco: To Rent or to Buy?
"[O]ur HIV status makes us look at life differently -- to ask some really tough questions," writes Sarah Sacco. In their latest blog entry, the Saccos consider buying a home -- one of many "normal" decisions that married couples make, but one that suddenly becomes more complicated when both partners have HIV.

Mark S. KingMark S. King: Farewell, Elizabeth
"It's impossible to overstate the impact Elizabeth Taylor has had on HIV/AIDS awareness and funding since the earliest days of the epidemic," writes blogger Mark S. King. "'With every breath of my being,' I remember her saying, 'I will fight this disease and for the rights of people with AIDS, until the day I die.'"

TheBody.com is home to more perspectives on the passing of Elizabeth Taylor, including this blog entry by Candace Y.A. Montague on Taylor's contributions to Washington, D.C., and amfAR's remembrance of one of its founding chairwomen.

  Back to Top


HIV Transmitted From Kidney Donor to Transplant Recipient in U.S.
For the first time in two decades, a person is confirmed to have become infected with HIV through an organ transplant in the U.S., scientists report. The discovery has led to recommendations that U.S. health workers implement stricter guidelines regarding when and how to test organ donors for HIV.

How We Can Make HIV Prevention Programs More Effective in the U.S. (Video)
Last month at CROI 2011, Jonathan Mermin, M.D., of the U.S. Centers for Disease Control and Prevention gave a presentation addressing how the U.S. should move forward with its HIV prevention interventions. In this AIDS.gov video, Mermin discusses what approaches work and what needs to be done in order to achieve the goals set by the National HIV/AIDS Strategy.

More Headlines on HIV/STD Transmission:

  Back to Top


Also Worth Noting

Top HIV/AIDS Clinical Developments of 2010

David Wohl, M.D.

Of the hundreds of published studies, presented research and other major developments in HIV this year, which are the most likely to change the way we approach HIV prevention or the care of our HIV-infected patients?

In one of our most popular annual updates (available this year on TheBody.com), David Wohl, M.D., takes an in-depth look at the highlights of 2010 and their clinical implications.

HIV Management Today

In HIV Management Today, an informative online series from TheBodyPRO.com, we consult with some of the top clinical minds in HIV on some of the most important issues in HIV/AIDS clinical management.

•  Assessing and Acting on Cardiovascular Disease Risk in HIV-Infected Patients, featuring Marshall Glesby, M.D., Ph.D., and Jens Lundgren, M.D.

•  A Closer Look at Tesamorelin (Egrifta), a Newly Approved Treatment for HIV-Associated Lipohypertrophy, featuring Daniel Berger, M.D.

•  New Paradigms of First-Line HIV Therapy: Determining When (and With What) to Start, featuring Eric Daar, M.D., and Trevor Hawkins, M.D.

•  Clinical Management of the HIV-Infected Woman, featuring Kimberly Smith, M.D., M.P.H., and Valerie Stone, M.D., M.P.H.